Microsoft has launched Copilot Healtha dedicated, secure space within its Copilot AI assistant that aggregates personal health data from wearable devices, electronic medical records and lab results, and then applies AI to display what the company calls a “coherent story” of a user’s health.
The product opened its waitlist on March 12, 2026 and is being launched in phases, initially to English-speaking adults in the United States.
The launch marks Microsoft’s most direct entry into AI for consumer health and places it alongside OpenAI, which introduced ChatGPT Health in January 2026, and Anthropic, which Claude for Healthcare launched the same month.
In the words of Dominic King, vice president of health at Microsoft AI: “2026 looks like an important year for consumer health.”
He told briefing attendees that Microsoft’s consumer AI products, Copilot and Bing, already answer more than 50 million health-related questions a day.
Copilot Health appears as a dedicated tab on the Copilot web interface and mobile app. Users create a health profile by entering basic details such as age and gender and then optionally connect data sources.
FFrom there, the tool can analyze lab results, interpret portable readings, make superficial connections between data streams, and help users prepare questions before clinical appointments.
The data plumbing
Three connectors power the personal health layer of the platform. Wearable data, covering activity levels, sleep patterns and vital signs, flows from more than 50 devices, with Apple Health, Oura and Fitbit cited as examples.
The electronic health records come from HealthEx, a US health data infrastructure provider whose network spans more than 52,000 healthcare organizations through direct exchange of FHIR terminals, as well as TEFCA individual access services in more than 12,000 organizations. Lab results are connected through Function, a venture-backed medical testing provider.
HealthEx confirmed the partnership in a separate press release issued the same day. The company’s co-founder and CEO Priyanka Agarwal, MD, described the integration as a way to give users access to their health history. “Through labs, medications, conditions, clinical notes and more” with the ability to revoke access at any time.
Microsoft itself confirmed that users can disconnect any connector instantly and that health data in Copilot Health is not used for training the AI model, a point the company has prominently repeated in all communications about the product.
For general health information, as opposed to personal data, Microsoft says it has high content from credible health organizations in 50 countries, with a selection of sources verified by its clinical team using standards set by the National Academy of Medicine.
Answers include quotes and links to sources. The platform also offers answer cards written by Harvard Health experts and connects to U.S. provider directories in real time, allowing users to search for doctors by specialty, location, languages spoken, and insurance coverage.
The AI roadmap: towards ‘medical superintelligence’
Microsoft is framing Copilot Health as a step toward a long-term goal it describes as “medical superintelligence,” a term the company has been using since at least late 2025. The vision is an AI that can combine the breadth of a general practitioner with the depth of a specialist.
The most cited vehicle for this ambition is Microsoft AI Diagnostic Orchestrator (MAI-DxO), a research-stage system that the company says has produced strong results in clinical evaluation settings.
Microsoft says upcoming publications will detail how MAI-DxO can be applied in a broader range of cases and conditions. The company states that any new AI features that build on these research capabilities will only be launched in Copilot Health after rigorous clinical evaluation and with clear labeling, a commitment that is interpreted as both a regulatory buffer and a product design principle.
“We truly believe we are on the path to medical superintelligence that brings together both the broad knowledge of a family or general practitioner and the deep experience of a specialist.” said Dominic King, vice president of health at Microsoft AI.
Privacy, governance and the HIPAA issue
Microsoft has been careful about data governance. Copilot Health data and conversations are stored separately from general Copilot interactions, are encrypted at rest and in transit, are subject to stricter access controls, and are not used for model training.
The product achieved ISO/IEC 42001 certification, the international standard for AI management systems, which requires third-party verification of how an organization builds, governs and improves its AI services.
The platform was also developed with an external advisory panel of more than 230 physicians from more than 24 countries, along with consumer advocacy organizations, including AARP, which serves 38 million older Americans, and the National Health Council, which represents more than 180 patient advocacy groups.
However, an important regulatory warning emerged during the press conferences. King confirmed that Copilot Health is not subject to HIPAA, the US federal law governing the privacy and security of patient health data, because it operates as a direct-to-consumer service where users share their own data, rather than as a covered healthcare entity.
King said: “HIPAA is not necessary for a direct consumer experience like this when you use your own data.” while adding that Microsoft intends to announce updates to its HIPAA controls. He declined to specify what those updates would entail.
This distinction matters. HIPAA compliance holds healthcare organizations to strict data handling, breach notification, and minimum necessary usage standards.
Consumer health platforms that fall outside of HIPAA, as Copilot Health does at launch, are not subject to the same enforcement regime. The FDA’s relaxation of rules on wearable clinical decision support in early 2026 adds further regulatory complexity: It means more AI-based health tools can reach consumers without premarket review by the FDA.
The clinical reception.
The initial reaction of experts has generally been cautious rather than hostile. Arjun Manrai, an assistant professor of biomedical informatics at Harvard Medical School, told Healthcare Brew that the approach makes strategic sense and describes how using personal context in AI health interactions will likely become a defining trend in 2026. He said helping people prepare for medical appointments is a good goal for large language models.
Doctors interviewed by the New York Times acknowledged that AI-assisted health tools could help people access health information at a time when care is increasingly expensive and doctors are increasingly strained.
But the same doctors raised concerns about the privacy risks of sharing records with big tech companies and the possibility that tools like Copilot Health could lead to unnecessary clinic visits by making users anxious about data patterns that may be clinically insignificant.
Microsoft’s standard disclaimer is located at the end of every Copilot Health communication: The product is not intended to diagnose, treat, or prevent any disease, and is not a substitute for professional medical advice.
